Control of Postoperative Pain with a Wearable Continuously Operating Pulsed Radiofrequency Energy Device: A Preliminary Study
Ian M. Rawe, Adam Lowenstein, C. Raul Barcelo & David G. Genecov
BioElectronics RecoveryRx® was investigated in a double blind, randomized and placebo controlled study for postoperative pain and narcotic pain medication use following breast augmentation surgery. The primary emphasis of the study was to investigate the temporal trajectory of how post-surgery VAS scores (AM, PM) decreased after discharge, and if this trajectory differed significantly across the active treatment or placebo treatment groups. These results of this analysis can be visualized in Figure 1.
Figure 1: The Active group indicated lower average pain and a quicker reduction in pain
In addition, 70% of patients in the treatment group indicated their pain was mild (i.e., 3 VAS points or lower) by day 3. This level of pain relief was not obtained in the placebo group until day 7.
Pain medication use also reflected these lower pain levels as shown in table 1.
Table 1. Narcotic pain medication use (total pills) was significantly lower in the group using RecoveryRx®
The study is published in the Aesthetics of Plastic Surgery.